Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Chinese investigators identify new TGFBR1 inhibitors

March 9, 2021

Artios Pharma divulges POLQ inhibitors

March 9, 2021

Idorsia Pharmaceuticals patents LGALS3 inhibitors

March 9, 2021

Collagen means well in pancreatic cancer

March 9, 2021

Chimerix opens enrollment in phase III study of dociparstat for AML

March 9, 2021

Incyte discloses CDK2/cyclin E inhibitors

March 8, 2021

BiSiChem identifies RIPK1 inhibitors

March 8, 2021

Taiho begins phase II study of TAS-117 in advanced solid tumors with germline PTEN mutations

March 8, 2021

Post-chemo bone marrow regeneration elucidated

March 8, 2021

CYH-33 demonstrates preliminary antitumor activity in PIK3CA-mutant tumors

March 5, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...